Supernus Pharma Should Have More Strength After Epilepsy Drug Patent Decision, Northland's Buck Says
March 10, 2016 at 11:23 AM EST
Supernus Pharmaceuticals Inc (NASDAQ: SUPN) is up more than 3 percent Thursday and more than 17 percent year-to-date. According ...